Patent details

EP1913157 Title: EGFR AND KRAS MUTATIONS FOR PREDICTION OF PATIENT RESPONSE TO EGFR INHIBITOR TREATMENT

Basic Information

Publication number:
EP1913157
PCT Application Number:
PCT/US/2006/023230
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP067732016
PCT Publication Number:
WO/2007/001868
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
EGFR AND KRAS MUTATIONS FOR PREDICTION OF PATIENT RESPONSE TO EGFR INHIBITOR TREATMENT
French Title of Invention:
MUTATIONS CHEZ EGFR ET KRAS POUR PREDIRE LA REPONSE D'UN PATIENT AU TRAITEMENT AVEC UN INHIBITEUR D'EGFR
German Title of Invention:
EGFR- UND KRAS-MUTATIONEN ZUR VORHERSAGE DER REAKTION EINES PATIENTEN AUF EGFR-HEMMER-BEHANDLUNG
SPC Number:

Dates

Filing date:
13/06/2006
Grant date:
28/11/2012
EP Publication Date:
28/11/2012
PCT Publication Date:
04/01/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/04/2008
EP B1 Publication Date:
28/11/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/06/2013
Expiration date:
13/06/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/06/2006
 
 

Name:
GENENTECH, INC.
Address:
1 DNA WAY, SOUTH SAN FRANCISCO CA 94080-4990, United States (US)

Inventor

Name:
HILLAN Kenneth, J.
Address:
United States (US)

Priority

Priority Number:
695174 P
Priority Date:
28/06/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
C12Q 1/68;
Filing date Document type Number of pages